HIV self-testing strategy, implementation in Latin America and Mexico, where we are going
DOI:
https://doi.org/10.5281/zenodo.10998649Keywords:
Prevention, Self-testing, HIVAbstract
HIV/AIDS emerged in the 1980s, creating an urgent need for detection tests. Laboratory tests to detect HIV antibodies in blood samples were developed, followed by rapid tests in the 1990s. In the 2000s, HIV self-testing kits were introduced, improving accuracy and ease of use. Self-testing has become crucial in the fight against HIV. By 2030, UNAIDS sets goals for detection and treatment. Despite progress, challenges such as stigma and education persist. In Latin America, national self-testing programs are being implemented, such as in Chile, Brazil, and Colombia. In Mexico, the approval of self-tests in 2024 represents a significant advancement. Self-tests are expected to be widely used to detect the disease early, ensuring privacy and reducing stigma and discrimination. They will also be used for research in vulnerable groups and to refer patients to PrEP services. With these actions, the aim is to achieve the goals set by UNAIDS and improve public health in the fight against HIV
Downloads
References
World Health Organization. (2016). Guidelines on HIV self-testing and partner notification: supplement to consolidated guidelines on HIV testing services. World Health Organization. https://iris.who.int/handle/10665/251655.
World Health Organization. Encourages countries to adapt HIV testing strategies in response to changing epidemic. WHO-CDS-HIV-19.34, consulta en fecha 24.04.2024 disponible en https://www.who.int/publications/i/item/WHO-CDS-HIV-19.34.
HIV and AIDS. Key facts. 2023, consulta en fecha 19.04.2024 disponible en https://www.who.int/es/news-room/fact-sheets/detail/hiv-aids.
ONUSIDA. Dia mundial del Sida 2023. Nota informativa 2023 consultada en fecha 2’.04.2024, disponible en https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_es.pdf.
Kyaddondo, D., Wanyenze, R.K., Kinsman, J. et al. Home-based HIV counseling and testing: Client experiences and perceptions in Eastern Uganda. BMC Public Health 12, 966 (2012). https://doi.org/10.1186/1471-2458-12-966.
Franks J, Hirsch-Moverman Y, Loquere AS Jr, et al. Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study. AIDS Behav. 2018;22(4):1139-1149. https://doi:10.1007/s10461-017-1964-6.
Ingold H, Mwerinde O, Ross AL, et al. The Self-Testing AfRica (STAR) Initiative: accelerating global access and scale-up of HIV self-testing. J Int AIDS Soc. 2019;22 Suppl 1(Suppl Suppl 1):e25249. https://doi:10.1002/jia2.25249.
Gumede SB, Wensing AMJ, Lalla-Edward ST, et al. Predictors of Treatment Adherence and Virological Failure Among People Living with HIV Receiving Antiretroviral Therapy in a South African Rural Community: A Sub-study of the ITREMA Randomised Clinical Trial. AIDS Behav. 2023;27(12):3863-3885 https://doi:10.1007/s10461-023-04103-2.
PAHO/WHO launches campaign to promote HIV self-testing in COVID-19 times. 2020, consulta en fecha 20.04.2024 disponible en https://www.paho.org/en/campaigns/world-aids-day-2020.
Ministerio de Salud de Gobierno de Chile, Programa autotestVIH. 2023, consulta en fecha 20.04.2024, disponible en https://saludresponde.minsal.cl/autotest-vih/#:~:text=La%20estrategia%20de%20autotest%20de,a%20un%20centro%20de%20salud.
Bones-Rocha, K., Torres de Carvalho, F., Almeida-Weber, J. L., Silvana-Both, N., & Pizzinato, A. (2017). Impacto de la implementación de la prueba rápida del VIH/ITS en un centro de atención especializada en Brasil. Revista Gerencia y Políticas de Salud, 16(32). consulta en fecha 20.04.2024, disponible en https://doi.org/10.11144/javeriana.rgps16-32.iipr.
Luque- Nuñez. Encuentro de farmacovigilancia de las Americas. El papel de las agencias regulatorias para alcanzar las metass en 20230 de ONUSIDA. Octubre 2023. Consuta en fecha 20.04.2024, disponible en https://www.paho.org/es/eventos/xviii-encuentro-internacional-farmacovigilancia-americas.
Asociacion Panamericana de Infectologia. Estándares de testeo y prevención en VIH para América Latina 2023. consulta en fecha 19.04.2024 disponible en https://www.researchgate.net/publication/374078419_Estandares_en_VIH_2023.
Comisión Federal para la Protección contra Riesgos Sanitarios. Cofepris expide autorización a autoprueba para diagnóstico de VIH. Comunicado conjunto31 de enero de 2024. consulta en fecha 24.04.2024 disponible en https://www.gob.mx/cofepris/articulos/cofepris-expide-autorizacion-a-autoprueba-para-diagnostico-de-vih.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Revista Médica del Instituto Mexicano del Seguro Social

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.